立昂技术(300603.SZ):参股公司元道通信于创业板IPO获证监会同意注册
格隆汇6月9日丨立昂技术(300603.SZ)公布,中国证监会于2022年6月8日发布《关于同意元道通信股份有限公司首次公开发行股票注册的批覆》,同意元道通信首次公开发行股票的注册申请,批覆自同意注册之日起12个月内有效。元道通信将根据中国证监会及深圳证券交易所相关规定及要求开展后续工作。
截至公吿披露日,公司持有元道通信217.6万股股份,占其发行前股份总数的2.39%,该部分股份自元道通信上市之日起12个月内不得转让。目前元道通信股份发行价格尚未确定,对公司未来财务状况和经营成果的影响暂无法确定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.